WuXi PharmaTech Installs Supercritical Fluid Chromatography System

WuXi PharmaTech Installs Supercritical Fluid Chromatography System

March 26, 2007

 
    SHANGHAI, China, March 26 /Xinhua-PRNewswire/ -- WuXi
PharmaTech, China's leading provider of pharmaceutical
R&D outsourcing services announced today that it has
purchased and successfully brought online a Berger
Supercritical Fluid Chromatography (SFC) MultiGram(R)III
preparative system.

    (Logo: http://www.xprn.com.cn/xprn/sa/200611271812.jpg
)

    Supercritical Fluid Chromatography (SFC) is a
relatively recent chromatographic technique offering
superior speed and efficiency for chiral separation and
compound purification.  Preparative SFC uses carbon dioxide
as mobile phase instead of organic solvents in HPLC, so it
is a green technology for rapid access to enantiomers in
pharmaceutical industry.

    "WuXi PharmaTech is the first company in China to
install a MultiGram(R)III and continues to be a leader in
the use of the most modern technology," noted Mr. Eric
Lim, General Manager of Lab Business, Mettler-Toledo China.

    As the company's third SFC, this latest addition will
play an important role in the research and separation of
chiral drugs and intermediates.  This preparative system
expands WuXi PharmaTech's chiral separation capability from
multi-grams to multi-kilograms.  It also greatly expands the
capability of WuXi PharmaTech's Kilogram-scale laboratories,
and enhancing the company's analytical efficiency.

    "WuXi PharmaTech is honored to be once again
setting the standard for research efficiency and quality in
China," commented Dr. Ning Zhao, Vice President of
Analytical Services, WuXi PharmaTech.  "Our goal is
simple: to provide the best and most efficient service
possible. Utilizing a MultiGram(R)III SFC system is a
logical next step", continued Dr. Zhao.
 
    About WuXi PharmaTech Co., Ltd.

    Founded in 2001, Shanghai-based WuXi PharmaTech is
China's leading drug R&D service company.  As a
research-driven and customer-focused company, WuXi
PharmaTech offers global pharmaceutical and
biopharmaceutical companies a diverse, value-added, and
fully integrated portfolio of outsourcing services ranging
from discovery chemistry, and process chemistry to service
biology, bioanalytical chemistry, and large scale GMP
manufacturing.  WuXi PharmaTech assists its global partners
in shortening the cycle and lowering the cost of drug
discovery and development by providing cost-effective and
efficient outsourcing solutions that save our clients both
time and money.  Currently, our client list consists of 19
of the top 20 pharmaceutical, and 8 of the top 10
biopharmaceutical companies.  For more information, please
visit http://www.pharmatechs.com .


    For more information, please contact:

     Sherry Shao
     Tel:   [phone]
     Email: [e-mail]